Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SNAI2 |
| Upstream (Parents) |
|---|
| (<<) DCN → SNAI2 |
| (<<) PCOLCE → SNAI2 |
| (<<) COL6A2 → SNAI2 |
| (<<) PXDN → SNAI2 |
| (<<) CAV1 → SNAI2 |
| Downstream (Children) |
|---|
| SNAI2 → ID3 (>>) |
| SNAI2 → EVC (>>) |
| SNAI2 → DCN (>>) |
| SNAI2 → PCOLCE (>>) |
| SNAI2 → PNMAL1 (>>) |
| SNAI2 → LAMA4 (>>) |
| SNAI2 → MAP3K12 (>>) |
| SNAI2 → ETV1 (>>) |
| SNAI2 → OLFML3 (>>) |
| SNAI2 → FGF1 (>>) |
| SNAI2 → CLIP3 (>>) |
| SNAI2 → FN1 (>>) |
| SNAI2 → MEG3 (>>) |
| SNAI2 → AKAP12 (>>) |
| SNAI2 → PDGFC (>>) |
| SNAI2 → PXDN (>>) |
| SNAI2 → CAV1 (>>) |
| SNAI2 → PKD2 (>>) |
| SNAI2 → TRIB2 (>>) |
| SNAI2 → MDFIC (>>) |
| SNAI2 → HTRA1 (>>) |
| SNAI2 → TTTY9B///TTTY9A (>>) |
| SNAI2 → CD93 (>>) |
